Caroline Fortier

Experimental oral candidosis in the mouse: microbiologic and histologic aspects

M. Lacasse, Caroline Fortier, Luc Trudel et al. · Journal of Oral Pathology and Medicine · 1990 · 36 citations

Dentistry, Infectious Diseases, Oral Pathology +17

Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumors

Quincy S. Chu, Nathaniel Bouganim, Caroline Fortier et al. · Investigational New Drugs · 2021 · 30 citations

Medicine, Oncology, Pharmacology +13

Acquired resistance and persistence of <i>Candida albicans</i> following oral candidiasis in the mouse: a model of the carrier state in humans

M. Lacasse, Caroline Fortier, Jamila Chakir et al. · Oral Microbiology and Immunology · 1993 · 26 citations

Life Sciences, Immunology, Microbiology +17

The Efficacy, Safety, and Pharmacology of a Ghrelin O-Acyltransferase Inhibitor for the Treatment of Prader-Willi Syndrome

Jennifer L. Miller, André Lacroix, Lynne M. Bird et al. · The Journal of Clinical Endocrinology & Metabolism · 2022 · 18 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

A phase Ib study of oral Chk1 inhibitor LY2880070 in combination with gemcitabine in patients with advanced or metastatic cancer.

Quincy S. Chu, Derek J. Jonker, Diane Provencher et al. · Journal of Clinical Oncology · 2020 · 14 citations

Medicine, Oncology, Pharmacology +15